<DOC>
	<DOCNO>NCT01887067</DOCNO>
	<brief_summary>To demonstrate efficacy renal denervation therapy treat resistant hypertension effect glucose metabolism patient type 2 diabetes mellitus</brief_summary>
	<brief_title>Renal Denervation Therapy Resistant Hypertension Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Age range 18 70 year inclusive Essential hypertension Office Systolic BP ( SBP ) ≥ 150 mmHg Diastolic BP ( DBP ) ≥ 90mmHg 3 antihypertensive medication different class , include diuretic , documented intolerance multiple medication Type 2 Diabetes Mellitus oral hypoglycaemic agent ( OHA ) 2 functional kidney ; eGFR ≥ 45 mL/min/1.73m² ( MDRD formula ) Suitable renal anatomy compatible endovascular denervation procedure Individual renal artery anatomy ineligible treatment include : Patients secondary hypertension Myocardial infarction , unstable angina pectoris , cerebrovascular accident within 6 month Patient type 1 diabetes mellitus Patient insulin due oral drug failure Renovascular abnormality ( include severe renal artery stenosis , previous renal stenting angioplasty , know dual renal artery ) Pregnancy Patient implantable device incompatible radiofrequency energy delivery Hemodynamically significant valvular heart disease reduction BP would consider hazardous Any serious medical condition , opinion investigator , may limit life expectancy patient adversely</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Diabetes Mellitus</keyword>
</DOC>